Industry Insights
Industry Leaders Provide an Update on COVID-19 Vaccine Progress
Industry InsightA number of biopharmaceutical industry leaders met in a virtual press conference today to outline progress in COVID-19 vaccine development. Here's what they had to say.
Read More
A Conversation on Vaccine Hesitancy in COVID-19 Times
Industry InsightTechnology Networks spoke with Jeff Wolf, Heat Biologics CEO, to discuss what vaccine hesitancy is, why it is problematic and the steps that need to be taken to prevent vaccine hesitancy.
Read More
Diagnosing Vitamin B12 Deficiency Anemia
Industry InsightBeckman Coulter has recently expanded their range of tools for anemia diagnosis, with the launch of the Access Active-B12 Assay. We spoke to Heather Read-Harper, European Senior Manager for Immunoassay and Clinical Chemistry at Beckman Coulter, to learn more about the assay and the advantages of detecting Active-B12.
Read More
Oral Vaccine for COVID-19 on Track Towards Human Clinical Trials
Industry InsightLast week, Vaxart announced that it has selected its lead COVID-19 vaccine candidate, and has contracted with KindredBio to manufacture the vaccine in bulk. Technology Networks interviewed Walter Latour, MD, CEO and Chairman of Vaxart, to delve deeper into oral vaccine technology, the preclinical results for the oral candidates for COVID-19 and the next steps in this space.
Read More
Testing for SARS-CoV-2 Using Fingerprint Sweat
Industry InsightIntelligent Fingerprinting and Imperial College London are working together to develop a rapid, non-invasive test for SARS-CoV-2, using a fingerprint-based method. To learn more about the project and the benefits a fingerprint test could offer, we spoke to Phil Hand, Executive Chairman, Intelligent Fingerprinting.
Read More
Developing Drugs for Difficult-to-treat Diseases
Industry InsightTechnology Networks recently spoke with Mike Sherman, Chief Executive Officer at Chimerix to learn more about the company’s oncology, biodefense and COVID-19 therapeutic efforts.
Read More
Improving Gene Editing by Promoting Error-free Repair of CRISPR/Cas9-cut DNA
Industry InsightWith the first clinical trial of CRISPR gene editing in progress and the controversy of the first gene-edited babies continuing to spark discussion, it is more important than ever to better understand not only the benefits but also the risks of CRISPR-based therapies.
Read More
Antibody Tests To Detect SARS-CoV-2 Immune Status
Industry InsightWe recently spoke with Shamiram Feinglass, Global Chief Medical Officer at Beckman Coulter, to learn more about antibody tests, what they can tell us, and the value of this information.
Read More
Real-time Antibody Titer Monitoring Advances Bioprocessing Capabilities
Industry InsightIn facilitating the move to continuous processing in biotherapeutic production, bioprocessing specialists are being driven to develop innovative analytical testing methods for key measurements of output and quality, such as antibody titer.
Read More
Tracking Global COVID-19 Clinical Trials
Industry InsightIn efforts to find efficacious interventions against SARS-CoV-2, the novel coronavirus that causes COVID-19, hundreds of clinical trials have been designed and launched at an unprecedented rate across the globe. As data emerges from these studies there is an urgent need to track progress, to ensure transparent communication of findings, and to avoid duplication of efforts. Technology Networks spoke with Cytel’s Edward Mills, Vice President of Real-World Evidence and Senior Principal Scientist, to learn more about the global COVID-19 Trial Tracker the company has recently launched.
Read More
